Medical care of pregnant women with type 1 diabetes: Current guidelines and clinical practice

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 1-2, 2013, Pages 59-65

  Cyganek, Katarzyna ^a   Klupa, Tomasz ^a   Szopa, Magdalena ^a   Katra, Barbara ^a   Malecki, Maciej T ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Pregnancy; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; LONG ACTING INSULIN; SHORT ACTING INSULIN;

BLOOD GLUCOSE MONITORING; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; FAMILY PLANNING; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MACROSOMIA; MATERNAL CARE; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; REVIEW; STILLBIRTH; WEIGHT GAIN;

EID: 84874707335     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1595     Document Type: Review

References (50)

1. McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011; 25: 945-958.
2. Jarosz-Chobot P, Polanska J, Szadkowska A, et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia. 2011; 54: 508-515.
3. Patterson CC, Dahlquist GG, Gyürüs E, et al.; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicentre prospective registration study. Lancet. 2009; 373: 2027-2033.
4. Taylor R, Davison JM. Type 1 diabetes and pregnancy. BMJ. 2007; 334: 742-745.
5. Ringholm L, Mathiesen ER, Kelstrup L, Damm P. Managing type 1 diabetes mellitus in pregnancy-from planning to breastfeeding. Nat Rev Endocrinol. 2012; 8: 659-667.
6. Bell R, Bailey K, Cresswell T, et al.; Northern Diabetic Pregnancy Survey Steering Group. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008; 115: 445-452.
7. Nielsen LR, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004; 27: 1200-1201.
8. Mills JL, Jovanovic L, Knopp R, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: The diabetes in early pregnancy study. Metabolism. 1998; 47: 1140-1144.
9. Casson IF, Clarke C, Howard C, et al. Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ. 1997; 315: 275-278.
10. Rosenn B, Miodovnik M, Combs CA, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994; 84: 515-520.
11. Confidential Enquiry into Maternal and Child Health, Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH 2005.
12. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM. 2001; 94: 435-444.
13. Murphy HR, Roland JM, Skinner TC, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: Benefits beyond glycemic control. Diabetes Care. 2010; 33: 2514-2520.
14. Wahabi HA, Alzeidan RA, Bawazeer GA, et al. Preconception care for diabetic women for improving maternal and fetal outcomes: A systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010; 10: 63-77.
15. Kitzmiller JL, Buchanan TA, Kjos S, et al. Pre-conception care of diabetes, congenital malformations and spontaneous abortions. Diabetes Care. 1996; 19: 514-541.
16. Damm P, Mathiesen E, Clausen TD, Petersen KR. Contraception for women with diabetes mellitus. Metab Syndr Relat Disord. 2005; 3: 244-249.
17. Cyganek K, Hebda-Szydlo A, Katra B, et al. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: The significance of pregnancy planning. Diabetes Technol Ther. 2010; 12: 41-47.
18. Owens LA, Avalos G, Kirwan B, et al. ATLANTIC DIP: Closing the loop: A change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care. 2012; 35: 1669-1671.
19. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ. 2004; 328: 915.
20. Clinical recommendations for management of patients with diabetes mellitus in 2012. Diabetologia Kliniczna. 2012; 1 (Supl. A): A41-A43. Polish.
21. Kerssen A, Evers IM, de Valk HW, Visser GH. Poor glucose control in women with type 1 diabetes mellitus and "safe" hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med. 2003; 13: 309-313.
22. Hermanides J, Phillip M, DeVries JH. Current application of continuous glucose monitoring in the treatment of diabetes: Pros and cons. Diabetes Care. 2011; 34 (Suppl 2): S197-S201.
23. Nowak N, Skupien J, Cyganek K, et al. 1,5-anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birth weight in pregnancy complicated by type 1 diabetes mellitus. Diabetologia. 2013 Feb 2. [Epub ahead of print].
24. Brogden RN, Heel RC. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs. 1987; 34: 350-371.
25. Bolli GB, Di Marchi RD, Park GD, et al. Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia. 1999; 42: 1151-1167.
26. González Blanco C, Ballesteros AC, Saladich IG, et al. Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: A systematic review and meta-analysis. Diabetes Technol Ther. 2011; 13: 907-911.
27. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther. 2007; 29 (Suppl D): S153-S160.
28. Hod M, Damm P, Kaaja R, et al.; Insulin Aspart Pregnancy Study Group: Fetal and perinatal outcomes in type 1 diabetes pregnancy: A randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008; 198: 186.e1-7.
29. Mathiesen ER, Kinsley B, Amiel SA, et al.; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: A randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007; 30: 771-776.
30. Garnock-Jones KP, Plosker GL. Insulin glulisine: A review of its use in the management of diabetes mellitus. Drugs. 2009; 69: 1035-1057.
31. Lapolla A, Di Cianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: A report on 10 Type 1 diabetic women. Diabet Med. 2009; 26: 1181-1182.
32. Lepercq J, Lin J, Hall GC, et al. Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy. Obstet Gynecol Int. 2012; 2012: 649070.
33. Mathiesen ER, Hod M, Ivanisevic M, et al.; Detemir in Pregnancy Study Group. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012; 35: 2012-2017.
34. Callesen NF, Damm J, Mathiesen JM, et al. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: Comparison of glycaemic control and pregnancy outcome. J Matern Fetal Neonatal Med. 2012 Dec 11. [Epub ahead of print].
35. Bergenstal RM, Tamborlane WV, Ahmann A, et al.; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010; 363: 311-320.
36. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Tamborlane WV, Beck RW, Bode BW. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359: 1464-1476.
37. Cummins E, Royle P, Snaith A, et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: Systematic review and economic evaluation. Health Technol Assess. 2010; 14: 1-181.
38. Nahata L. Insulin therapy in pediatric patients with type I diabetes: Continuous subcutaneous insulin infusion versus multiple daily injections. Clin Pediatr (Phila). 2006; 45: 503-508.
39. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. 2007; 3: CD005542.
40. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009; 32: 1947-1953.
41. Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in diabetic pregnancy-a randomised controlled trial. Diabetologia. 2012; 55 (Suppl 1): 83.
42. Higgins M, Galvin D, McAuliffe F, et al. Pregnancy in women with Type 1 and Type 2 diabetes in Dublin. Ir J Med Sci. 2011; 180: 469-473.
43. Jovanovic L. Glucose and insulin requirements during labor and delivery: The case for normoglycemia in pregnancies complicated by diabetes. Endocr Pract. 2004; 10 (Suppl 2): 40-45.
44. de Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 65-76.
45. Gold AE, Reilly C, Walker JD. Transient improvement in glycemic control. The impact of pregnancy in women with IDDM. Diabetes Care. 1998; 21: 374-378.
46. Cyganek K, Hebda-Szydlo A, Skupien J, et al. Postpregnancy Glycemic Control and Weight Changes in Type 1 Diabetic Women. Diabetes Care. 2012 Dec 18. [Epub ahead of print].
47. Evagelidou EN, Kiortsis DN, Bairaktari ET, et al. Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care. 2006; 29: 1197-1201.
48. Johnstone FD, Lindsay RS, Steel J. Type 1 diabetes and pregnancy: Trends in birth weight over 40 years at a single clinic. Obstet Gynecol. 2006; 107: 1297-1302.
49. Klemetti M, Nuutila M, Tikkanen M, et al. Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008. Diabetologia. 2012; 55: 2327-2334.
50. Choudhary P, Shin J, Wang Y, et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011; 34: 2023-2025.